Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.51 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.47 |
| ▸ | CPB2 | Q96IY4 | 11/20 | 0.43 |
| ▸ | GSR | P00390 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29187387 | 0.84 | FOLH1 (0.57) | FOLH1SLC6A5CPB2GSRCA1 | |
| SCHEMBL13049083 | 0.84 | FOLH1 (0.57) | FOLH1SLC6A5CPB2GSRCA1 | |
| SCHEMBL18741275 | 0.83 | FOLH1 (0.55) | FOLH1SLC6A5CPB2GSRCA1 | |
| SCHEMBL29918590 | 0.83 | FOLH1 (0.55) | FOLH1SLC6A5CPB2GSRCA1 | |
| SCHEMBL18741276 | 0.83 | FOLH1 (0.55) | FOLH1SLC6A5CPB2GSRCA1 | |
| SCHEMBL22689972 | 0.81 | FOLH1 (0.54) | FOLH1SLC6A5CPB2GSRCA1 | |
| SCHEMBL22689833 | 0.81 | FOLH1 (0.54) | FOLH1SLC6A5CPB2GSRCA1 | |
| SCHEMBL7165076 | 0.79 | FOLH1 (0.50) | FOLH1SLC6A5CPB2GSRCA1 | |
| SCHEMBL27509822 | 0.79 | FOLH1 (0.58) | FOLH1SLC6A5CPB2GSRCA1 | |
| SCHEMBL7165075 | 0.79 | FOLH1 (0.50) | FOLH1SLC6A5CPB2GSRCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2345635-A1 | AMINO ACID DERIVATIVE | Nippon Zoki Pharmaceutical Co., Ltd. (JP) | 2011-07-20 | — | — | EP | disclosed |